Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure

American Journal of Cardiology

Volumn 81, Issue 4, 1998, Pages 443-447

  Hamilton, Michele A ^a   Stevenson, Lynne W ^a   Fonarow, Gregg C ^a   Steimle, Anthony ^a   Goldhaber, Joshua I ^a   Child, John S ^a   Chopra, Inder J ^a   Moriguchi, Jaime D ^a   Hage, Antoine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HEART HEMODYNAMICS; HEART RHYTHM; HUMAN; MALE; PRIORITY JOURNAL; THYROID HORMONE METABOLISM;

FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; TRIIODOTHYRONINE;

EID: 0032519597     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00950-8     Document Type: Article

References (23)

1. 1. Hamilton MA, Stevenson LW, Luu M, Walden JA. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990;16:91-95.
2. 2. Hamilton MA. Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. Ann Thorac Surg 1993;56:S48-S53.
3. 3. Novitsky D, Cooper DKC, Barton CI, Greer A, Chaffin J, Grim J, Zindhi N. Triiodothyronine as an inotropic agent after open-heart surgery. J Thorac Cardiovasc Surg 1989;98:972-978.
4. 4. Hesch RD, Husch M, Kodding R, Hofflen B, Meyer T. Treatment of dopamine-dependent shock with triiodothyronine. Endoc Res Commun 1981;8:229-237.
5. 5. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med 1964;27:403-409.
6. 6. Klemperer JD, Zelano J, Helm RE, Berman K, Ojamaa K, Klein I, Isom OW, Krieger K. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J Thorac Cardiovasc Surg 1995;109:457-465.
7. 7. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K. Thyroid hormone treatment after coronary artery bypass surgery. N Engl J Med 1995;333:1522-1527.
8. 8. Bennett-Guerrero E, Jimenez JL, White WD, D'Amico EB, Baldwin BI, Schwinn DA. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. JAMA 1996;275:687-692.
9. 9. Ojamaa K, Klemperer JD, Klein IL. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996;6:505-512.
10. 10. Davis PJ, Davis FB. Nongenomic actions of thyroid hormone. Thyroid 1996;6:497-504.
11. 11. Walker JD, Crawford FA, Mukherjee MS, Spinale FG. The direct effects of 3,5,3′-triiodothyronine (T3) on myocyte contractile processes. J Thorac Cardiovasc Surg 1995;110:1369-1380.
12. 12. Brent FA. The molecular basis of thyroid hormone action. N Engl J Med 1994;331:847-853.
13. 13. Ladenson PW, Goldenheim PD, Ridgeway C. Rapid pituitary and peripheral tissue responses to intravenous L-triiodothyronine in hypothyroidism. J Clin Endocrinol Metab 1983;56:1252-1259.
14. 14. Maruzzi P, Doria E, Agostani PG, Capacchione V, Sganzerla P. Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol 1994;73:374-378.
15. 15. Chopra IJ. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrin Metab 1997;82:329-334.
16. 16. Slag MF, Morley JE, Eldon MK, Crowson TW, Nuttal FQ, Shafer RB. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 1981;24:35-43.
17. 17. Utiger RD. Altered thyroid function in non-thyroid illness and surgery. To treat or not to treat? N Engl J Med 1995;333:1562-1563.
18. 18. Ladenson PW, Kieffer JD, Farwell AP, Ridgeway EC. Modulation of myocardial L-triiodothyronine receptors in normal, hypothyroid, and hyperthyroid rats. Metabolism 1986;35:5-12.
19. 19. Wortsman J, Premachandra BN, Chopra IJ, Murphy JE. Hypothyroxinemia in cardiac arrest. Arch Intern Med 1987;147:245-248.
20. 20. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, BiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, et al. Effect of milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325:1468-1475.
21. 21. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med 1990;88:626-630.
22. 22. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Sacaa L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996;334:809-814.
23. 23. Pennock GD, Raya TE, Bahl JJ, Goldman S, Morkine E. Combination treatment with captropril and the thyroid hormone analog 3,5-diiodothyropropionic acid. Circulation 1993;88:1289-1298.